Online poker looks like a skill game, but the fee matters as much as the cards. That fee is the rake, and it quietly pulls ...

Novo Nordisk is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe on the company's patents, and is seeking to recover damages. The move escalates the ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Hims & Hers (HIMS) shares dropped 16% after-hours as FDA plans to restrict compounded GLP-1 ingredients and HHS referred Hims to DOJ. Hims projected $725M in weight-loss revenue for 2025 from total ...

Hims & Hers Health launched a cheaper, compounded version of the new Wegovy pill in a move that reignites its competition with Novo Nordisk in the U.S. obesity-drug market. Shares of of Hims & Hers ...

Last December, several members of a national organization for math education leaders came together to issue a warning. A growing movement in the field, they claimed, was calling on schools to adopt an ...

For many individuals, growing uncomfortable with mathematics often starts in early childhood when they receive a worksheet with numbers on it. At this point in life, there may be feelings of panic, ...

The Hechinger Report covers one topic: education. Sign up for our newsletters to have stories delivered to your inbox. Consider becoming a member to support our nonprofit journalism. Students, parents ...

In an era defined by rapid technological advancements and shifting market dynamics, businesses are increasingly turning to innovative strategies to achieve scalable growth. Compounding, a ...

Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up. Contact me ...